Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer
Clinical trial NCT06356519 · UNKNOWN
Trial details
- NCT number
- NCT06356519
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-03-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.